Clinical trial

Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes

NCT05792995

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-12-21

PhasePHASE2

Study timeline

Study start (actual)2021-12-21Date precision: day

Registry last updated2023-03-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

SindillimabDRUG

Sponsors & collaborators

Xin-Hua Xulead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05792995 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.